Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) saw some unusual options trading activity on Tuesday. Stock traders purchased 12,132 call options on the stock. This represents an increase of approximately 94% compared to the typical volume of 6,245 call options.
Aurora Cannabis Price Performance
Shares of ACB traded up $0.70 during trading hours on Tuesday, reaching $5.01. The company had a trading volume of 14,423,424 shares, compared to its average volume of 2,067,483. The firm has a 50 day simple moving average of $3.72 and a 200-day simple moving average of $4.57. Aurora Cannabis has a 12-month low of $2.84 and a 12-month high of $11.50. The company has a market capitalization of $272.97 million, a price-to-earnings ratio of -1.73 and a beta of 2.36. The company has a current ratio of 3.79, a quick ratio of 2.45 and a debt-to-equity ratio of 0.14.
Aurora Cannabis (NASDAQ:ACB - Get Free Report) last issued its quarterly earnings results on Thursday, February 8th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.10). The company had revenue of $53.34 million for the quarter, compared to analyst estimates of $45.94 million. Aurora Cannabis had a negative return on equity of 23.27% and a negative net margin of 48.82%. Research analysts expect that Aurora Cannabis will post -0.85 earnings per share for the current year.
Wall Street Analyst Weigh In
Separately, Canaccord Genuity Group raised shares of Aurora Cannabis from a "hold" rating to a "buy" rating in a research report on Friday, February 9th.
Check Out Our Latest Analysis on ACB
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of ACB. Advisor Group Holdings Inc. raised its position in Aurora Cannabis by 9.7% in the first quarter. Advisor Group Holdings Inc. now owns 61,873 shares of the company's stock valued at $309,000 after purchasing an additional 5,488 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Aurora Cannabis by 824.7% during the 1st quarter. JPMorgan Chase & Co. now owns 371,269 shares of the company's stock valued at $1,485,000 after buying an additional 331,120 shares during the period. Raymond James & Associates lifted its position in Aurora Cannabis by 93.5% during the 1st quarter. Raymond James & Associates now owns 32,457 shares of the company's stock worth $130,000 after acquiring an additional 15,687 shares in the last quarter. HighTower Advisors LLC purchased a new position in Aurora Cannabis in the 1st quarter worth approximately $50,000. Finally, Citigroup Inc. boosted its holdings in Aurora Cannabis by 566.4% in the 1st quarter. Citigroup Inc. now owns 14,334 shares of the company's stock worth $57,000 after acquiring an additional 12,183 shares during the period. Hedge funds and other institutional investors own 47.63% of the company's stock.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Further Reading
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
